Tvardi Therapeutics Inc. (TVRD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tvardi Therapeutics Inc.

    NASDAQ: TVRD · Real-Time Price · USD
    40.23
    2.86 (7.65%)
    At close: Oct 03, 2025, 3:59 PM
    40.22
    -0.02%
    Pre-market: Oct 06, 2025, 07:52 AM EDT

    Tvardi Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Cash & Equivalents
    		 20.65M 34.22M 37.9M 9.44M 49.24M 47M 22.92M 63.28M
    Short-Term Investments
    		 20.35M n/a n/a 4.97M 7.38M 22.78M 48.98M 15.67M
    Long-Term Investments
    		 n/a n/a n/a n/a 1.5M 1.5M 1.5M 6.25M
    Other Long-Term Assets
    		 17K n/a n/a 1.1M n/a n/a -1.48M n/a
    Receivables
    		 n/a 2.24M 4.5M n/a 1.82M 2.92M 4.02M 5.73M
    Inventory
    		 n/a 900K 900K n/a 1.64M 2.74M n/a 3.27M
    Other Current Assets
    		 n/a n/a n/a n/a n/a n/a -4.02M n/a
    Total Current Assets
    		 43.13M 38.95M 43.83M 10.7M 63.86M 81.22M 26.16M 100.6M
    Property-Plant & Equipment
    		 249K n/a n/a 310K 7.14M 7.37M 378K 8.49M
    Goodwill & Intangibles
    		 354K n/a n/a 401K n/a n/a 448K n/a
    Total Long-Term Assets
    		 620K n/a n/a 1.81M 8.64M 8.87M 843K 14.73M
    Total Assets
    		 43.75M 38.95M 43.83M 12.51M 72.5M 90.1M 27M 115.34M
    Account Payables
    		 2.42M 4K 1.43M 1.98M 6.75M 4.98M 1.61M 7.98M
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Short-Term Debt
    		 109K n/a n/a n/a 168K 220K n/a 497K
    Other Current Liabilities
    		 7.4M 606K 1.97M 1.19M 5.76M 7.83M 942K 9.04M
    Total Current Liabilities
    		 10.68M 1.2M 3.97M 5.31M 13.9M 15.1M 3.28M 22.88M
    Long-Term Debt
    		 n/a n/a 44.45M n/a 39.68M 38.38M n/a n/a
    Other Long-Term Liabilities
    		 n/a 45.82M n/a 85.5M n/a n/a 85.5M n/a
    Total Long-Term Liabilities
    		 145K 45.82M 44.45M 85.71M 47M 45.2M 85.78M 6.82M
    Total Liabilities
    		 10.82M 47.02M 48.42M 91.02M 60.9M 60.3M 89.06M 29.7M
    Total Debt
    		 254K 45.82M 44.45M 299K 47.16M 45.42M 368K 7.31M
    Book Value
    		 32.93M -8.07M -4.59M -78.5M 11.6M 29.8M -62.06M 85.64M
    Book Value Per Share
    		 3.99 -0.86 -3.01 -51.53 7.63 3.19 -6.63 56.85
    Common Stock
    		 9K 2K 5K 19K 54K 54K 19K 54K
    Retained Earnings
    		 -97.65M -760.52M -755.61M -79.53M -735.46M -715.44M -62.84M -652.41M
    Comprehensive Income
    		 -13K n/a n/a n/a -121K -191K n/a -439K
    Shareholders Equity
    		 32.93M -8.07M -4.59M -78.5M 11.6M 29.8M -62.06M 85.64M
    Total Investments
    		 20.35M n/a n/a 4.97M 8.88M 24.28M 50.48M 21.91M

    Add to Watchlist